by aparada | Jun 10, 2021 | News FJB, Press Release |
Wyss Institute at Harvard to Utilize FairJourney Biologics Expertise in Antibody Discovery Collaboration FairJourney Biologics to co-develop antibody compounds that would shuttle drugs to the brain via known and novel targets The collaboration will see FairJourney...
by aparada | May 10, 2021 | News FJB, Press Release |
Hubrecht Institute licenses Flow Eighteen38 reagent antibodies for cancer research Antibodies generated by Flow Eighteen38 to be used as research tools by Hubrecht Institute. Agreement to leverage FairJourney Biologics llama naïve libraries. Porto, Portugal and...
by aparada | Nov 23, 2020 | News FJB, News IONTAS, Press Release |
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research Porto, Portugal, Cambridge and London, UK, 23rd November 2020: FairJourney Biologics S.A...
by aparada | Oct 13, 2020 | News FJB, News IONTAS, Press Release |
IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...
by aparada | Sep 28, 2020 | News FJB, Press Release |
IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency · Panel of 15 potent antibodies selected that are optimally suited to clinical development and manufacturing · Monoclonal antibodies have the potential to both...
by aparada | Apr 5, 2014 | Press Release
FairJourney Biologics, BioRap Technologies and Hadasit Medical Research Services and Development Ltd. collaborate to discover therapeutic antibodies that modulate Heparanase, a validated target for cancer therapy. Press release
